Compare
NextTrip, Inc. vs Virgin Galactic Holdings, Inc vs Maitong Sunshine Cultural Development Co., Ltd vs Strata Critical Medical, Inc.
| Latest fiscal year | NextTrip, Inc. NTRP | Virgin Galactic Holdings, Inc SPCE | Maitong Sunshine Cultural Development Co., Ltd MGSD | Strata Critical Medical, Inc. SRTA |
|---|---|---|---|---|
| Year ended | 2026-02-28 | 2025-12-31 | 2025-09-30 | 2025-12-31 |
| Revenue | $3.72M | $1.54M | $1.38M | $197.14M |
| Revenue growth (YoY) | +641.0% | -78.1% | +71.5% | +34.3% |
| Gross margin | 17.6% | n/m (computed) | 41.1% | 20.9% |
| Operating margin | -440.5% | n/m | 6.3% | -11.3% |
| Net margin | -428.3% | n/m | -1.5% | 21.0% |
| Net income | -$15.91M | -$278.91M | -$21.2K | $41.35M |
| EPS (Diluted) | -$1.82 | -$5.44 | $0.00 | $0.50 |
| Operating cash flow | -$4.56M | -$240.14M | -$674.8K | -$48.91M |
| Free cash flow | n/a | -$438.19M | n/a | -$58.51M |
| Cash & equivalents | $1.70M | $144.73M | $4.4K | $30.97M |
| Total assets | $13.08M | $803.18M | $439.1K | $325.47M |
| Total liabilities | $7.32M | $529.22M | $393.3K | $46.40M |
| Shareholders' equity | $5.37M | $273.96M | $45.8K | $279.07M |
| Return on year-end equity | -296.1% | -101.8% | -46.4% | 14.8% |
| Shares outstanding | 13.98M | 73.33M | 60.50M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | NextTrip, Inc. | Virgin Galactic Holdings, Inc | Maitong Sunshine Cultural Development Co., Ltd | Strata Critical Medical, Inc. |
|---|---|---|---|---|
| Latest | $3.72M Ended 2026-02-28 | $1.54M Ended 2025-12-31 | $1.38M Ended 2025-09-30 | $197.14M Ended 2025-12-31 |
| 1 year earlier | $501.4K Ended 2025-02-28 | $7.04M Ended 2024-12-31 | $804.9K Ended 2024-09-30 | $146.82M Ended 2024-12-31 |
| 2 years earlier | $458.8K Ended 2024-02-29 | $6.80M Ended 2023-12-31 | n/a | $225.18M Ended 2023-12-31 |
| 3 years earlier | $382.8K Ended 2023-02-28 | $2.31M Ended 2022-12-31 | n/a | $146.12M Ended 2022-12-31 |
| 4 years earlier | n/a | $3.29M Ended 2021-12-31 | n/a | n/a |